Marco Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Marco Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.4M	Buy	10,991 +145	+1%	+$78.7K	0.41%	60
2025 Q4	$6.28M	Buy	10,846 +70	+0.6%	+$39.6K	0.47%	55
2025 Q3	$5.23M	Sell	10,776 -386	-3%	-$180K	0.4%	58
2025 Q2	$4.53M	Sell	11,162 -400	-3%	-$167K	0.38%	58
2025 Q1	$5.75M	Sell	11,562 -345	-3%	-$187K	0.53%	47
2024 Q4	$6.19M	Sell	11,907 -490	-4%	-$269K	0.53%	52
2024 Q3	$7.67M	Buy	12,397 +370	+3%	+$219K	0.66%	44
2024 Q2	$6.65M	Sell	12,027 -3	-0%	-$1.72K	0.61%	46
2024 Q1	$6.99M	Sell	12,030 -128	-1%	-$71.8K	0.66%	48
2023 Q4	$6.45M	Sell	12,158 -197	-2%	-$95.4K	0.66%	46
2023 Q3	$6.25M	Buy	12,355 +118	+1%	+$62.9K	0.72%	44
2023 Q2	$6.38M	Buy	12,237 +286	+2%	+$154K	0.69%	44
2023 Q1	$6.89M	Sell	11,951 -150	-1%	-$84.5K	0.78%	43
2022 Q4	$6.66M	Sell	12,101 -246	-2%	-$130K	0.78%	43
2022 Q3	$6.26M	Sell	12,347 -424	-3%	-$237K	0.79%	41
2022 Q2	$6.94M	Sell	12,771 -200	-2%	-$110K	0.81%	42
2022 Q1	$7.66M	Sell	12,971 -10	-0.1%	-$5.74K	0.78%	42
2021 Q4	$8.66M	Sell	12,981 -193	-1%	-$121K	0.85%	40
2021 Q3	$7.53M	Buy	13,174 +13	+0.1%	+$7.13K	0.83%	37
2021 Q2	$6.64M	Buy	13,161 +7,731	+142%	+$3.65M	0.77%	37
2021 Q1	$2.48M	Hold	5,430	–	–	0.32%	74
2020 Q4	$2.53M	Sell	5,430 -5	-0.1%	-$2.34K	0.36%	67
2020 Q3	$2.4M	Sell	5,435 -75	-1%	-$31K	0.39%	60
2020 Q2	$2M	Hold	5,510	–	–	0.37%	62
2020 Q1	$1.56M	Buy	5,510 +500	+10%	+$158K	0.33%	65
2019 Q4	$1.63M	Sell	5,010 -60	-1%	-$18.2K	0.25%	79
2019 Q3	$1.48M	Buy	5,070 +310	+7%	+$88.8K	0.25%	80
2019 Q2	$1.4M	Sell	4,760 -15	-0.3%	-$4.13K	0.25%	82
2019 Q1	$1.31M	Sell	4,775 -1,400	-23%	-$348K	0.24%	83
2018 Q4	$1.38M	Buy	6,175 +100	+2%	+$23.5K	0.27%	81
2018 Q3	$1.48M	Buy	6,075 +15	+0.2%	+$3.45K	0.21%	86
2018 Q2	$1.25M	Hold	6,060	–	–	0.19%	92
2018 Q1	$1.25M	Sell	6,060 -3,700	-38%	-$777K	0.19%	92
2017 Q4	$1.85M	Sell	9,760 -420	-4%	-$80.5K	0.28%	82
2017 Q3	$1.93M	Sell	10,180 -1,400	-12%	-$254K	0.3%	78
2017 Q2	$2.02M	Sell	11,580 -2,300	-17%	-$386K	0.33%	75
2017 Q1	$2.06M	Hold	13,880	–	–	0.35%	74
2016 Q4	$1.96M	Hold	13,880	–	–	0.34%	81
2016 Q3	$2.21M	Hold	13,880	–	–	0.4%	73
2016 Q2	$2.05M	Hold	13,880	–	–	0.38%	78
2016 Q1	$1.97K	Sell	13,880 -700	-5%	-$93.8K	0.28%	81
2015 Q4	$2.07M	Sell	14,580 -300	-2%	-$40K	0.38%	78
2015 Q3	$1.82M	Hold	14,880	–	–	0.36%	86
2015 Q2	$1.93M	Buy	14,880 +200	+1%	+$26.1K	0.32%	87
2015 Q1	$1.97M	Buy	14,680 +1,300	+10%	+$168K	0.34%	80
2014 Q4	$1.68M	Buy	13,380 +1,200	+10%	+$146K	0.21%	89
2014 Q3	$1.48M	Buy	12,180 +2,200	+22%	+$267K	0.2%	88
2014 Q2	$1.18M	Buy	9,980 +2,700	+37%	+$318K	0.23%	92
2014 Q1	$875K	Sell	7,280 -600	-8%	-$71.3K	0.18%	98
2013 Q4	$877	Hold	7,880	–	–	0.05%	97
2013 Q3	$726K	Hold	7,880	–	–	0.17%	103
2013 Q2	$667K	Buy	+7,880	New	+$656K	0.19%	79

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marco Investment Management's TMO Position: Q1 2026 in Review

Marco Investment Management increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2026, buying an estimated $78.7K and bringing the position to 10,991 shares worth $5.4M. The position accounts for 0.41% of the portfolio, ranked #60.

Marco Investment Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.66M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Marco Investment Management held 10,991 shares of Thermo Fisher Scientific worth $5.4M as of Q1 2026.
Marco Investment Management bought 145 Thermo Fisher Scientific shares in Q1 2026, an estimated $78.7K.
Thermo Fisher Scientific made up 0.41% of Marco Investment Management's portfolio in Q1 2026, its #60 holding.
Marco Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
Marco Investment Management's Thermo Fisher Scientific position peaked at $8.66M in Q4 2021.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.